| | |||||
| lung cancer | |||||
| 新闻 | |||||
| |||||
| |||||
| Anti-GPC3 Therapies Market Gains Traction with Key Players Advancing Pipeline ... - Yahoo Finance ... carcinoma (HCC), Non-small cell lung cancer (NSCLC), Gastric cancer, and ... Carcinoma, Non-Small Cell Lung Cancer, Gastric Cancer, and Others ...
| |||||
| BeOne's Tevimbra gains EU nod for front-line nasopharyngeal cancer - FirstWord Pharma ... , first-line extensive-stage small-cell lung cancer, and multiple non–small-cell lung cancer indications across first- and second-line settings.
| |||||
| 查看更多结果 | 修改此快讯 | |||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment